GlassScriptPhysician profile
Shahnaz Miri
NPI 1043605397
$2,670.41
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,003 · 2020: $222 · 2022: $184 · 2023: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $260.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,891.89 | 2019-2020 | |
| Neurelis, INC. | $275.83 | 2022-2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $131.46 | 2019 | |
| Sk Life Science, INC. | $119.30 | 2023 | Xcopri |
| Boston Scientific Corporation | $107.17 | 2019 | |
| Adamas Pharmaceuticals, INC. | $63.13 | 2020 | |
| Horizon Therapeutics Plc | $49.73 | 2022 | |
| Avanir Pharmaceuticals, INC. | $31.90 | 2019-2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shahnaz Miri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.